clonidine has been researched along with corticosterone in 109 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (28.44) | 18.7374 |
1990's | 22 (20.18) | 18.2507 |
2000's | 17 (15.60) | 29.6817 |
2010's | 34 (31.19) | 24.3611 |
2020's | 5 (4.59) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Good, AC; Peterson, SJ; Richards, WG | 1 |
Giacomini, KM; Schaner, ME; Zhang, L | 1 |
Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Andrisano, V; Barril, X; Bartolini, M; Carreiras, Mdo C; de los Ríos, C; García, AG; Huertas, O; León, R; López, B; López, MG; Luque, FJ; Marco-Contelles, J; Rodríguez-Franco, MI; Samadi, A; Villarroya, M | 1 |
Andrisano, V; Arce, MP; Badia, A; Bartolini, M; Camps, P; Clos, MV; Dafni, T; Formosa, X; Galdeano, C; Gómez, E; Huertas, O; Isambert, N; Lavilla, R; Luque, FJ; Mancini, F; Muñoz-Torrero, D; Ramírez, L; Rodríguez-Franco, MI | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Arce, MP; Conde, S; García, AG; González-Muñoz, GC; López, B; López, MG; Pérez, C; Rodríguez-Franco, MI; Villarroya, M | 1 |
Akamatsu, M | 1 |
Arce, MP; Conde, S; del Barrio, L; Egea, J; García, AG; González-Muñoz, GC; León, R; López, B; López, MG; Martín-de-Saavedra, MD; Pérez, C; Rodríguez-Franco, MI; Romero, A; Villarroya, M | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Andrisano, V; Bartolini, M; Clos, MV; Di Pietro, O; Juárez-Jiménez, J; Lavilla, R; Luque, FJ; Muñoz-Torrero, D; Pérez, B; Ramón, R; Viayna, E; Vicente-García, E | 1 |
Clos, MV; Di Pietro, O; Espargaró, A; Juárez-Jiménez, J; Lavilla, R; Luque, FJ; Muñoz-Torrero, D; Pérez, B; Pérez-Areales, FJ; Sabaté, R | 1 |
Clos, MV; Di Pietro, O; Espargaró, A; Galdeano, C; Guillou, C; Lamuela-Raventós, RM; Luque, FJ; Muñoz-Torrero, D; Pérez, B; Pérez-Areales, FJ; Ragusa, IM; Sabaté, R; Vallverdú-Queralt, A; Viayna, E | 1 |
Kong, LY; Lan, JS; Li, SY; Pan, LF; Wang, XB; Xie, SS | 1 |
Artigas, A; Clos, MV; Gbedema, SY; Kelly, JM; Muñoz-Torrero, D; Pérez, B; Sola, I; Taylor, MC; Wright, CW | 1 |
Jiang, N; Kong, LY; Lan, JS; Li, ZR; Wang, KD; Wang, X; Xie, SS; Yu, W | 1 |
Berenguer, D; Clos, MV; Di Pietro, O; Fisa, R; Kelly, JM; Lanzoni, A; Lavilla, R; Muñoz-Torrero, D; Pérez, B; Riera, C; Sayago, H; Sola, I; Taylor, MC; Viayna, E; Vicente-García, E | 1 |
Jiang, N; Kong, LY; Lan, JS; Li, F; Wang, J; Wang, X; Wang, ZM; Wu, JJ; Xie, SS | 1 |
Alencar, N; Di Pietro, O; Esteban, G; Juárez-Jiménez, J; Luque, FJ; Muñoz-Torrero, D; Pérez, B; Sola, I; Solé, M; Szałaj, N; Unzeta, M; Vázquez, J; Viayna, E | 1 |
Kong, LY; Li, F; Li, XM; Wang, J; Wang, XB; Wang, ZM; Wu, JJ | 1 |
Cai, P; Kong, LY; Liu, QH; Wang, XB; Wang, ZM; Wu, JJ; Xu, DQ; Yang, XL | 1 |
Artigas, A; Clos, MV; Kelly, JM; Muñoz-Torrero, D; Pérez, B; Pérez-Areales, FJ; Sola, I; Taylor, MC; Viayna, E; Wright, CW | 1 |
Cai, P; Kong, L; Liu, Q; Wang, KDG; Wang, X; Wang, Z; Wu, J; Yang, X | 1 |
Guo, QL; Huang, SL; Huang, ZS; Li, D; Liu, ZQ; Ou, TM; Tan, JH; Wang, HG; Wang, N; Wu, JQ; Xia, CL | 1 |
Arce, MP; Conde, S; Egea, J; Gil, C; León, R; López, MG; Monjas, L; Pérez, C; Rodríguez-Franco, MI; Villarroya, M | 1 |
Cai, P; Kong, LY; Li, F; Liu, QH; Wang, J; Wang, XB; Wu, JJ; Yang, XL | 1 |
Cai, P; Kong, LY; Li, F; Liu, QH; Wang, J; Wang, XB; Wu, JJ; Yang, HL; Yang, XL | 1 |
Cai, P; Kong, LY; Li, F; Wang, J; Wang, XB; Wu, JJ; Yang, XL | 1 |
Cai, P; Fang, SQ; Kong, LY; Liu, QH; Tang, YW; Wang, C; Wang, XB; Yang, HL; Yang, XL | 1 |
Dong, SN; Gong, Q; Li, J; Li, XK; Liu, WW; Mao, F; Tang, Y; Wang, H; Wang, TD; Xu, YX; Zhang, HY; Zhu, J | 1 |
Huang, Q; Jiang, N; Li, Q; Liang, N; Liu, J; Xie, SS | 1 |
Gong, Q; Li, J; Li, X; Liu, W; Mao, F; Qiu, X; Wang, H; Wang, W; Xu, Y; Zhang, H; Zhang, J; Zhu, J | 1 |
Cai, P; Kong, LY; Liu, QH; Shi, CJ; Tang, YW; Wang, XB; Yang, HL; Yang, XL | 1 |
Andrisano, V; Barniol-Xicota, M; Bartolini, M; De Simone, A; Espargaró, A; Muñoz-Torrero, D; Pérez, B; Pérez-Areales, FJ; Pivetta, D; Pont, C; Sabate, R; Sureda, FX; Turcu, AL; Vázquez, S | 1 |
Huang, M; Jiang, N; Kong, LY; Lan, JS; Wang, XB; Yin, FC | 1 |
Ji, L; Kong, L; Li, S; Liu, X; Lu, D; Luo, H; Peng, W; Qu, L; Wang, C; Wang, X; Yin, F | 1 |
Chen, L; Lei, Z; Sun, J; Sun, X; Wang, Y; Yue, S | 1 |
Brea, JM; Companys-Alemany, J; Griñán-Ferré, C; Johnson, JW; Kurnikova, MG; Loza, MI; Pallàs, M; Patel, DS; Pérez, B; Phillips, MB; Soto, D; Sureda, FX; Turcu, AL; Vázquez, S | 1 |
Endo, T; Starke, K; Taube, HD | 1 |
Jezová-Repceková, D; Kulifajová, A; Vigas, M | 1 |
Bravo, EL; Dustan, HP; Tarazi, RC | 1 |
Gunion, MW; Hoyt, MA; Miller, S; Rosenthal, MJ; Yonzon, DB | 1 |
Grealy, M; O'Donnell, JM | 2 |
Kawano, K; Koike, K; Takayanagi, I | 1 |
Marshall, IG; Prior, C; Wannan, G | 1 |
Caffrey, JL; Carter, GC; Hathorne, LF; Sinclair, RJ | 1 |
Bugajski, J; Gadek-Michalska, A; Połczyńska-Konior, G; Turoń, M | 1 |
Freeman, GB; Thurmond, JB | 1 |
Antelman, SM; Edwards, DJ; Knopf, S; Kocan, D | 1 |
Daniels, WM; Jaffer, A; Russell, VA; Searson, A; Taljaard, JJ | 1 |
Berridge, CW; Dunn, AJ | 1 |
Bialik, RJ; Roberts, DC; Sardelis, M; Smythe, JW | 1 |
Bradshaw, JE; Gleeson, RM; Grunstein, HS; Nicholson, MV; Smythe, GA | 1 |
Chandra, A; Diliberto, EJ; Dixon, WR; Holaday, JW; Lewis, JW; Long, JB; Tortella, FC; Unsworth, CD; Viveros, OH; Way, EL | 1 |
Neal, BS; Sparber, SB | 1 |
Jhanwar-Uniyal, M; Leibowitz, SF; Roland, CR | 1 |
Jhanwar-Uniyal, M; Leibowitz, SF | 1 |
Lane, LA; McGivern, RF; Noble, EP; Poland, RE | 1 |
Ignar, DM; Kuhn, CM | 1 |
Manev, H; Pericić, D | 1 |
Erwin, VG; Zgombick, JM | 1 |
Lakić, N; Manev, H; Pericić, D | 1 |
Bhakthavatsalam, P; Leibowitz, SF | 1 |
Gayk, W; Merker, R; Montel, H; Starke, K | 1 |
Iversen, LL; Salt, PJ | 1 |
Poyser, RH; Shorter, JH; Whiting, RL | 1 |
Salt, PJ | 1 |
Bugajski, J; Zacny, E | 1 |
Drew, GM; Sullivan, AT | 1 |
Bugajski, J; Gadek, A | 1 |
Grahame-Smith, DG; Steiner, JA | 2 |
Eisenberg, RM | 1 |
Pirke, KM; Spyra, B | 1 |
Gonzalvez, ML; Marín, MT; Martinez-Piñero, MG; Milanés, MV; Vargas, ML | 1 |
Borycz, J; Bugajski, J; Gadek-Michalska, A; Wieczorek, E | 1 |
Anglade, G; Faudon, M; Grino, M; Paulmyer-Lacroix, O; Renard, M | 1 |
Borycz, J; Bugajski, AJ; Bugajski, J; Gadek-Michalska, A | 2 |
Borycz, J; Bugajski, J; Gadek-Michalska, A | 1 |
Hermans, RH; Longo, LD | 1 |
Daniels, WM; Jaffer, A; Russell, VA; Taljaard, JJ | 1 |
Borycz, J; Bugajski, AJ; Bugajski, J; Gadek-Michalska, A; Głód, R | 2 |
Borycz, J; Bugajski, J; Gadek-Michalska, A; Głód, R; Ołowska, A | 1 |
Flores, LE; Francini, F; Gagliardino, JJ | 1 |
Calhau, C; Gründemann, D; Martel, F; Schömig, E | 1 |
Bugajski, AJ; Bugajski, J; Gadek-Michalska, A; Głód, R | 2 |
Dygalo, NN; Kalinina, TS; Kobzev, VF; Saharov, DG; Shishkina, GT; Sournina, NY | 1 |
Barna, I; Gyires, K; Müllner, K; Palkovits, M; Reichart, A; Rónai, AZ | 1 |
Baumann, MH; Milchanowski, AB; Rothman, RB | 1 |
Buijs, RM; Kalsbeek, A; La Fleur, S; Van Heijningen, C | 1 |
Clark, KA; Mohankumar, PS; Mohankumar, SM; Shin, AC; Sirivelu, MP | 1 |
Milot, MR; Plamondon, H | 1 |
Muck-Šeler, D; Pivac, N; Švob Štrac, D | 1 |
Cline, MA; Khan, MSI; Ogino, M; Tachibana, T | 1 |
Jung, JS; Kim, SS; Lee, JR; Lim, SM; Park, SH; Sharma, N; Suh, HW | 1 |
Diez-Alarcia, R; Horrillo, I; Meana, JJ; Ortega, JE; Urigüen, L | 1 |
Fernandes, MF; Fuller, B; Horman, T; Leri, F; Tigert, M; Zhou, Y | 1 |
Clark, KA; Jacob, EB; MohanKumar, PS; MohanKumar, SMJ | 1 |
Brakenridge, SC; Efron, PA; Kannan, KB; Loftus, TJ; Mira, JC; Mohr, AM | 1 |
109 other study(ies) available for clonidine and corticosterone
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods.
Topics: Carbolines; Chemical Phenomena; Chemistry, Physical; Electrochemistry; Imidazoles; Indoles; Molecular Structure; Pyridines; Structure-Activity Relationship | 1993 |
Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
Topics: Carrier Proteins; Corticosterone; HeLa Cells; Humans; Membrane Proteins; Midazolam; Organic Cation Transporter 1; Permeability; Recombinant Proteins; Structure-Activity Relationship; Tetraethylammonium Compounds; Transfection | 1998 |
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism | 1999 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Blood-Brain Barrier; Butyrylcholinesterase; Calcium; Calcium Channel Blockers; Catalytic Domain; Cell Death; Cell Line, Tumor; Cholinesterase Inhibitors; Cytosol; Dihydropyridines; Humans; Hydrogen Peroxide; Kinetics; Ligands; Models, Molecular; Peptide Fragments; Permeability; Tacrine | 2009 |
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Binding Sites; Blood-Brain Barrier; Butyrylcholinesterase; Cattle; Cholinesterase Inhibitors; Drug Design; Humans; Isomerism; Membranes, Artificial; Mice; Models, Molecular; Molecular Conformation; Permeability; Protein Binding; Tacrine | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Catalytic Domain; Cattle; Cell Death; Cell Line, Tumor; Cell Survival; Cholinergic Agents; Cholinesterase Inhibitors; Esters; Glutamic Acid; Humans; Hydrophobic and Hydrophilic Interactions; Neuroprotective Agents; Permeability; Piperidines; Protein Binding | 2009 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antineoplastic Agents; Butyrylcholinesterase; Calcium; Cell Death; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Okadaic Acid; Peptide Fragments; Phenothiazines; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
Topics: Acetylcholinesterase; Animals; Binding Sites; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Electrophorus; Humans; Membranes, Artificial; Models, Biological; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Naphthyridines; Permeability; Protein Binding | 2014 |
Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cholinesterase Inhibitors; Cholinesterases; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Naphthyridines; Structure-Activity Relationship; Tacrine; tau Proteins; Tauopathies | 2014 |
Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.
Topics: Acetylcholinesterase; Aminoquinolines; Amyloid beta-Peptides; Antioxidants; Catechols; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Heterocyclic Compounds, 4 or More Rings; Humans; Molecular Structure; Protein Aggregates; Protein Aggregation, Pathological; Structure-Activity Relationship; tau Proteins | 2014 |
Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; Carbolines; Cell Line; Chelating Agents; Cholinesterase Inhibitors; Drug Design; Electrophorus; Horses; Humans; Molecular Docking Simulation; Protein Aggregation, Pathological; Tacrine | 2014 |
Synthesis and antiprotozoal activity of oligomethylene- and p-phenylene-bis(methylene)-linked bis(+)-huprines.
Topics: Antimalarials; Antiprotozoal Agents; Humans; Molecular Structure; Structure-Activity Relationship | 2014 |
Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Benzopyrans; Blood-Brain Barrier; Brain; Cell Survival; Cells, Cultured; Cholinesterase Inhibitors; Coumarins; Drug Design; Erythrocytes; Humans; Kinetics; Models, Molecular; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroblastoma; Piperazines; Tacrine | 2015 |
Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity.
Topics: Acetylcholinesterase; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electrophorus; Leishmania infantum; Molecular Structure; Parasitic Sensitivity Tests; Quinolines; Rats; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosoma cruzi | 2015 |
Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Butyrylcholinesterase; Cell Line, Tumor; Cholinesterase Inhibitors; Cholinesterases; Coumarins; Donepezil; Dose-Response Relationship, Drug; Drug Design; Eels; Humans; Indans; Models, Molecular; Molecular Structure; Molecular Targeted Therapy; Piperidines; Structure-Activity Relationship | 2016 |
Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors.
Topics: Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Structure-Activity Relationship | 2016 |
Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; Catalytic Domain; Cell Line, Tumor; Chelating Agents; Cholinesterase Inhibitors; Donepezil; Electrophorus; Horses; Humans; Indans; Indoles; Iron; Kinetics; Melatonin; Molecular Docking Simulation; Peptide Fragments; Piperidines; Protein Multimerization; Rats; Zinc | 2016 |
Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Cell Survival; Cholinesterase Inhibitors; Copper; Donepezil; Drug Design; Humans; Indans; Kinetics; Liver; Mice; Models, Molecular; Peptide Fragments; Piperidines; Protein Aggregates; Protein Conformation | 2016 |
Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl-, and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agents.
Topics: Aminoquinolines; Brain; Dose-Response Relationship, Drug; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei | 2016 |
Neuroprotective effects of benzyloxy substituted small molecule monoamine oxidase B inhibitors in Parkinson's disease.
Topics: Animals; Apoptosis; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Mice; Mice, Inbred Strains; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Rats; Small Molecule Libraries; Structure-Activity Relationship | 2016 |
Design, synthesis and evaluation of 2-arylethenyl-N-methylquinolinium derivatives as effective multifunctional agents for Alzheimer's disease treatment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; Cell Death; Cell Line; Cholinesterase Inhibitors; Drug Design; Glutathione; Humans; Quinolines; Reactive Oxygen Species | 2017 |
Enzymatic and solid-phase synthesis of new donepezil-based L- and d-glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemia.
Topics: Alzheimer Disease; Animals; Brain Ischemia; Calcium Channel Blockers; Cholinesterase Inhibitors; Donepezil; Glutamates; Hippocampus; Humans; Indans; Neuroprotective Agents; Piperidines; Rats; Solid-Phase Synthesis Techniques | 2017 |
Synthesis and pharmacological evaluation of novel chromone derivatives as balanced multifunctional agents against Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Apoptosis; Binding Sites; Blood-Brain Barrier; Chromones; Copper; Humans; Hydrogen Peroxide; Inhibitory Concentration 50; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Protein Structure, Tertiary; Rats; Reactive Oxygen Species; Structure-Activity Relationship | 2017 |
Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-β aggregation for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Male; Mice; Mice, Inbred Strains; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; PC12 Cells; Protein Aggregates; Rats; Structure-Activity Relationship | 2017 |
Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Benzylamines; Blood-Retinal Barrier; Butyrylcholinesterase; Cell Death; Cholinergic Agents; Cholinesterase Inhibitors; Cinnamates; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Rats; Structure-Activity Relationship | 2017 |
Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Humans; Hydrogen Peroxide; Imines; Ligands; Lipopolysaccharides; Mice; Microglia; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; PC12 Cells; Peptide Fragments; Protein Aggregates; Rats; Salicylates; Structure-Activity Relationship | 2017 |
Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognitive Dysfunction; Dose-Response Relationship, Drug; Drug Discovery; Humans; Imidazoles; Mice; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Propylamines; Pyrimidines; Rats; Scopolamine; Structure-Activity Relationship; Thiourea | 2018 |
Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Cell Line, Tumor; Cholinesterase Inhibitors; Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Kinetics; Male; Mice; Mice, Inbred Strains; Models, Molecular; Molecular Structure; Peptide Fragments; Protein Aggregates; Range of Motion, Articular; Structure-Activity Relationship; Thiocarbamates | 2018 |
Design, synthesis and evaluation of vilazodone-tacrine hybrids as multitarget-directed ligands against depression with cognitive impairment.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Depression; Drug Design; Ligands; Mice; Permeability; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship; Tacrine; Vilazodone Hydrochloride | 2018 |
Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Blood-Brain Barrier; Cell Line; Dimerization; Humans; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Oxidative Stress; Prenylation; Rats; Resveratrol; Structure-Activity Relationship | 2019 |
A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors.
Topics: Acetylcholinesterase; Adamantane; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Tacrine | 2019 |
Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Topics: | 2020 |
Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Antioxidants; Aspartic Acid Endopeptidases; Azoles; Binding Sites; Blood-Brain Barrier; Cyclic S-Oxides; Drug Design; Humans; Interleukin-6; Isoindoles; Ligands; Mitochondria; Molecular Docking Simulation; Neuroprotective Agents; NF-E2-Related Factor 2; Organoselenium Compounds; Oxidative Stress; Peptide Fragments; Reactive Oxygen Species; Selenium; Signal Transduction; Thiadiazines | 2021 |
Development of 5-hydroxyl-1-azabenzanthrone derivatives as dual binding site and selective acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Binding Sites; Blood-Brain Barrier; Cholinesterase Inhibitors; Drug Design; Rats | 2022 |
Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Caenorhabditis elegans; Disease Models, Animal; Memantine; Mice; Receptors, N-Methyl-D-Aspartate | 2022 |
Pre- and postsynaptic components in effect of drugs with alpha adrenoceptor affinity.
Topics: Action Potentials; Adrenergic alpha-Agonists; Animals; Clonidine; Cocaine; Corticosterone; In Vitro Techniques; Methoxamine; Muscle Contraction; Neurons; Norepinephrine; Oxymetazoline; Phenylephrine; Propranolol; Pulmonary Artery; Rabbits; Receptors, Adrenergic; Synapses | 1975 |
Effects of phentolamine and clonidine on pituitary-adrenocortical axis during stress in conscious rats.
Topics: Animals; Clonidine; Corticosterone; Male; Phentolamine; Pituitary-Adrenal System; Rats; Restraint, Physical; Stress, Physiological | 1978 |
Multifactorial analysis of chronic hypertension induced by electrolyte-active steroids in trained, unanesthetized dogs.
Topics: Acebutolol; Aldosterone; Animals; Chronic Disease; Clonidine; Corticosterone; Diet, Sodium-Restricted; Disease Models, Animal; Dogs; Guanethidine; Hemodynamics; Hypertension; Male; Metyrapone; Norepinephrine; Premedication; Renin | 1977 |
Role of hypothalamic paraventricular nucleus alpha- and beta-adrenergic receptors in regulation of blood glucose, free fatty acids and corticosterone.
Topics: Animals; Blood Glucose; Catecholamines; Clonidine; Corticosterone; Fatty Acids, Nonesterified; Injections, Subcutaneous; Isoproterenol; Male; Methoxamine; Microinjections; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stress, Psychological | 1992 |
Neuroendocrine response to clonidine and 8-OH-DPAT in rats following chronic administration of desipramine or sertraline.
Topics: 1-Naphthylamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Cerebral Cortex; Clonidine; Corticosterone; Desipramine; Dihydroalprenolol; Male; Neurosecretory Systems; Prolactin; Rats; Rats, Inbred Strains; Receptors, Serotonin; Sertraline; Tetrahydronaphthalenes | 1992 |
Effects of aging on alpha 2-adrenoceptor mechanisms in isolated guinea-pig tracheal preparations.
Topics: Adrenergic alpha-Agonists; Aging; Animals; Clonidine; Corticosterone; Dinoprost; Guinea Pigs; In Vitro Techniques; Kinetics; Male; Microsomes; Muscle Contraction; Muscle, Smooth; Norepinephrine; Prostaglandin D2; Receptors, Adrenergic, alpha; Trachea | 1991 |
Alpha-adrenoceptor blocking properties of vesamicol.
Topics: Adrenergic alpha-Antagonists; Animals; Clonidine; Corticosterone; Desipramine; Dioxanes; Electric Stimulation; Idazoxan; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Piperidines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Stereoisomerism; Vas Deferens | 1991 |
Secretion of growth hormone elicited by intravenous desipramine in the conscious, unrestrained rat.
Topics: Animals; Clonidine; Corticosterone; Desipramine; Dioxanes; Growth Hormone; Hypothalamo-Hypophyseal System; Idazoxan; Injections, Intravenous; Male; Pituitary-Adrenal System; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1991 |
Naloxone potentiates contractile responses to epinephrine in isolated canine arteries.
Topics: Animals; Clonidine; Corticosterone; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Dynorphins; Epinephrine; Muscle Contraction; Muscle, Smooth, Vascular; Naloxone; Norepinephrine; Peptide Fragments; Phenylephrine; Receptors, Opioid; Renal Artery | 1990 |
Effects of systemic and intracerebroventricular phenylephrine and clonidine on corticosterone secretion in rats.
Topics: Animals; Clonidine; Corticosterone; Injections, Intraperitoneal; Injections, Intraventricular; Male; Phenylephrine; Prazosin; Rats; Rats, Inbred Strains; Yohimbine | 1990 |
Monoamines and effects of chlordiazepoxide on the corticosterone response to stress.
Topics: Animals; Apomorphine; Biogenic Amines; Chlordiazepoxide; Clonidine; Corticosterone; Hydroxyindoleacetic Acid; Male; Mice; Quipazine; Stress, Physiological | 1986 |
Persistent sensitization of clonidine-induced hypokinesia following one exposure to a stressor: possible relevance to panic disorder and its treatment.
Topics: Animals; Clonidine; Corticosterone; Fear; Male; Methoxyhydroxyphenylglycol; Motor Activity; Norepinephrine; Panic; Pentylenetetrazole; Rats; Rats, Inbred Strains; Stress, Psychological | 1989 |
The effect of partial noradrenergic denervation on corticosterone secretion in the rat.
Topics: Adrenergic Fibers; Animals; Benzylamines; Brain; Clonidine; Corticosterone; Isoproterenol; Male; Rats; Rats, Inbred Strains | 1989 |
Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF.
Topics: Animals; Benzylamines; Biogenic Amines; Brain; Clonidine; Corticosterone; Corticotropin-Releasing Hormone; Exploratory Behavior; Male; Mice; Mice, Inbred Strains; Neurotoxins; Norepinephrine; Phenylephrine; Prazosin; Restraint, Physical; Stress, Physiological | 1989 |
Adrenal demedullation blocks and brain norepinephrine depletion potentiates the hyperglycemic response to a variety of stressors.
Topics: Adrenal Medulla; Animals; Blood Glucose; Brain; Clonidine; Corticosterone; Deoxyglucose; Electric Stimulation; Hypothalamus; Isoproterenol; Male; Norepinephrine; Rats; Rats, Inbred Strains; Stress, Physiological | 1989 |
The central vs. peripheral effects of clonidine on ACTH, corticosterone and glucose release.
Topics: Adrenocorticotropic Hormone; Animals; Blood Glucose; Clonidine; Corticosterone; Deoxyglucose; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Pituitary-Adrenal System; Rats; Rats, Inbred Strains | 1985 |
Multiple opiate receptors: functional implications.
Topics: Adrenal Medulla; Adrenalectomy; Animals; Azocines; Behavior, Animal; Binding Sites; Blood Pressure; Clonidine; Corticosterone; Enkephalins; Naloxone; Receptors, Opioid; Stress, Physiological; Sympathetic Nervous System | 1985 |
Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
Topics: Animals; Body Temperature; Clonidine; Corticosterone; Dibenzazepines; Male; Mianserin; Morphine Dependence; Naloxone; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Serotonin; Substance Withdrawal Syndrome | 1986 |
Diurnal rhythm of alpha 2-noradrenergic receptors in the paraventricular nucleus and other brain areas: relation to circulating corticosterone and feeding behavior.
Topics: Animals; Brain; Circadian Rhythm; Clonidine; Corticosterone; Feeding Behavior; Male; Norepinephrine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Tissue Distribution | 1986 |
Impact of circulating corticosterone on alpha 1- and alpha 2-noradrenergic receptors in discrete brain areas.
Topics: Adrenalectomy; Animals; Brain Chemistry; Clonidine; Corticosterone; Hypothalamus; Male; Norepinephrine; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha | 1986 |
Influence of prenatal ethanol exposure on hormonal responses to clonidine and naloxone in prepubescent male and female rats.
Topics: Animals; Brain; Catecholamines; Clonidine; Corticosterone; Endorphins; Female; Fetal Alcohol Spectrum Disorders; Luteinizing Hormone; Male; Naloxone; Pregnancy; Rats; Rats, Inbred Strains; Sex Factors; Synaptic Transmission | 1986 |
Relative ontogeny of opioid and catecholaminergic regulation of thyrotropin secretion in the rat.
Topics: Aging; Animals; Animals, Newborn; Apomorphine; Body Temperature; Catecholamines; Clonidine; Cold Temperature; Corticosterone; Male; Morphine; Naloxone; Rats; Rats, Inbred Strains; Thyrotropin; Thyrotropin-Releasing Hormone | 1988 |
Progabide, a GABA mimetic drug, stimulates the secretion of plasma corticosterone in rats.
Topics: Animals; Anticonvulsants; Clonidine; Corticosterone; Dexamethasone; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Male; Picrotoxin; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1987 |
Central mechanisms of ethanol-induced adrenocortical response in selectively bred lines of mice.
Topics: Alcohol Deterrents; Animals; Carbachol; Clonidine; Corticosterone; Ethanol; Halothane; Male; Mice; Phentolamine; Propranolol; Yohimbine | 1987 |
Mechanisms by which picrotoxin and a high dose of diazepam elevate plasma corticosterone level.
Topics: Animals; Apomorphine; Atropine; Bicuculline; Clonidine; Corticosterone; Dexamethasone; Diazepam; Drug Interactions; Female; Haloperidol; Picrotoxin; Rats; Rats, Inbred Strains; Yohimbine | 1986 |
Alpha 2-noradrenergic feeding rhythm in paraventricular nucleus: relation to corticosterone.
Topics: Adrenalectomy; Animals; Clonidine; Corticosterone; Deoxyglucose; Feeding Behavior; Injections; Injections, Intraperitoneal; Male; Norepinephrine; Paraventricular Hypothalamic Nucleus; Periodicity; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. Alpha-sympathomimetic inhibition of Neurogenic vasoconstriction.
Topics: Adrenergic alpha-Agonists; Animals; Clonidine; Cocaine; Corticosterone; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Phentolamine; Propranolol; Pulmonary Artery; Rabbits; Receptors, Adrenergic; Sympathetic Nervous System; Time Factors; Tritium | 1974 |
Catecholamine uptake sites in the rat heart after 6-hydroxydopamine treatment and in a genetically hypertensive strain.
Topics: Animals; Catecholamines; Clonidine; Corticosterone; Heart; Hydroxydopamines; Hypertension; In Vitro Techniques; Male; Myocardium; Norepinephrine; Rats; Sympathectomy; Tritium | 1973 |
Proceedings: The production of hypertension and the effects of some antihypertensive agents in the conscious unrestrained cat.
Topics: Animals; Antihypertensive Agents; Cats; Cellophane; Clonidine; Corticosterone; Delayed-Action Preparations; Disease Models, Animal; Guanethidine; Hydralazine; Hypertension; Ligation; Methyldopa; Pempidine | 1974 |
Inhibition of noradrenaline uptake 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines.
Topics: Animals; Clonidine; Coronary Vessels; Corticosterone; Depression, Chemical; Dose-Response Relationship, Drug; Estradiol; Gonadal Steroid Hormones; Guinea Pigs; Heart Rate; In Vitro Techniques; Kinetics; Myocardium; Norepinephrine; Perfusion; Phenethylamines; Progesterone; Testosterone | 1972 |
Effect of intracerebroventricular clonidine on serum corticosterone levels in rats.
Topics: Adrenocorticotropic Hormone; alpha-Methyltyrosine; Animals; Clonidine; Corticosterone; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Methyltyrosines; Phenoxybenzamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1984 |
Pharmacological characterisation of pre- and postsynaptic alpha-adrenoceptors in dog saphenous vein.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Cocaine; Corticosterone; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Female; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Norepinephrine; Pulmonary Artery; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Saphenous Vein; Sympathetic Nervous System; Vasoconstriction | 1980 |
Interference of clonidine and alpha-methyl-p-tyrosine with stress and central histaminergic stimulation of the corticosterone response in rats.
Topics: Adrenergic alpha-Antagonists; alpha-Methyltyrosine; Animals; Brain; Clonidine; Corticosterone; Histamine; Immobilization; Male; Methyltyrosines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Histamine; Stress, Physiological | 1984 |
Central pharmacological control of corticosterone secretion in the intact rat. Demonstration of cholinergic and serotoninergic facilitatory and alpha-adrenergic inhibitory mechanisms.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Clonidine; Corticosterone; Male; Oxotremorine; Parasympathetic Nervous System; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Serotonin | 1980 |
Influence of clonidine on the acute dependence response elicited in naive rats by naloxone.
Topics: Animals; Clonidine; Corticosterone; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Morphine; Naloxone; Opioid-Related Disorders; Rats; Rats, Inbred Strains; Time Factors | 1983 |
The effect of repeated electroconvulsive shock on corticosterone responses to centrally acting pharmacological stimuli in the male rat.
Topics: 5-Hydroxytryptophan; Animals; Central Nervous System Agents; Clonidine; Corticosterone; Electroshock; Male; Methyltyrosines; Oxotremorine; Rats; Time Factors; Vasopressins | 1980 |
Catecholamine turnover in the brain and the regulation of luteinizing hormone and corticosterone in starved male rats.
Topics: Albuterol; Animals; Apomorphine; Brain; Catecholamines; Clonidine; Corticosterone; Dopamine; Hypothalamus; Levodopa; Luteinizing Hormone; Male; Median Eminence; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Starvation | 1982 |
Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naive rats and after naloxone-induced withdrawal.
Topics: Animals; Clonidine; Corticosterone; Hypothalamus; Injections, Intraventricular; Male; Morphine Dependence; Naloxone; Norepinephrine; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid; Substance Withdrawal Syndrome | 1994 |
Effect of crowding on corticosterone responses to central adrenergic stimulation.
Topics: Animals; Clonidine; Corticosterone; Crowding; Hypothalamo-Hypophyseal System; Injections, Intraventricular; Isoproterenol; Male; Norepinephrine; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic; Stress, Psychological | 1994 |
Blockade of alpha 2-adrenoceptors stimulates basal and stress-induced adrenocorticotropin secretion in the developing rat through a central mechanism independent from corticotropin-releasing factor and arginine vasopressin.
Topics: Adrenergic alpha-Antagonists; Adrenocorticotropic Hormone; Animals; Animals, Newborn; Arginine Vasopressin; Brain; Catecholamines; Clonidine; Corticosterone; Corticotropin-Releasing Hormone; Dioxanes; Dose-Response Relationship, Drug; Idazoxan; In Vitro Techniques; Locus Coeruleus; Lypressin; Pituitary Gland; Rats; Rats, Sprague-Dawley; Reference Values; Stress, Physiological | 1994 |
Calcium channel blockers impair the pituitary-adrenocortical responses to central adrenergic receptors stimulation.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Clonidine; Corticosterone; Drug Interactions; Hypothalamo-Hypophyseal System; Isoproterenol; Male; Nifedipine; Phenylephrine; Pituitary-Adrenal System; Rats; Rats, Wistar; Stimulation, Chemical; Verapamil | 1993 |
Social crowding stress diminishes the pituitary-adrenocortical and hypothalamic histamine response to adrenergic stimulation.
Topics: Animals; Clonidine; Corticosterone; Crowding; Histamine; Hypothalamo-Hypophyseal System; Injections, Intraventricular; Isoproterenol; Male; Phenylephrine; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Stimulation, Chemical; Stress, Psychological; Sympathetic Nervous System; Sympathomimetics | 1993 |
Altered catecholaminergic behavioral and hormonal responses in rats following early postnatal hypoxia.
Topics: Animals; Apomorphine; Arousal; Behavior, Animal; Catecholamines; Clonidine; Corticosterone; Dose-Response Relationship, Drug; Female; Fetal Hypoxia; Haloperidol; Hypothalamo-Hypophyseal System; Male; Motor Activity; Pituitary-Adrenal System; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Stereotyped Behavior | 1994 |
Central histaminergic mechanisms in the corticosterone response to clonidine.
Topics: Animals; Brain; Clonidine; Corticosterone; Histamine; Histamine Antagonists; Hypothalamo-Hypophyseal System; Hypothalamus; Male; Methylhistidines; Pituitary-Adrenal System; Rats; Rats, Wistar; Yohimbine | 1993 |
Alpha 2- and beta-adrenergic stimulation of corticosterone secretion in rats.
Topics: Animals; Clonidine; Corticosterone; Male; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Yohimbine | 1993 |
Effect of indomethacin on the pituitary-adrenocortical response to adrenergic stimulation.
Topics: Adrenal Cortex; Adrenergic Agents; Animals; Clonidine; Corticosterone; Cyclooxygenase Inhibitors; Epinephrine; Indomethacin; Isoproterenol; Male; Norepinephrine; Phenylephrine; Pituitary Gland; Rats; Rats, Wistar | 1996 |
The role of prostaglandins and the hypothalamic and hippocampal histamine in the clonidine-induced pituitary-adrenocortical response.
Topics: Adrenergic alpha-Agonists; Animals; Clonidine; Corticosterone; Hippocampus; Histamine; Hypothalamus; Indomethacin; Male; Pituitary-Adrenal System; Prostaglandins; Rats; Rats, Wistar | 1996 |
Modulatory effect of hormones on insulin secretion in vitro in the toad.
Topics: Adrenocorticotropic Hormone; Animals; Bufo arenarum; Cattle; Clonidine; Corticosterone; Dihydrotestosterone; Epinephrine; Estradiol; Estrone; Glucagon; Glucose; Hormones; Humans; Insulin; Insulin Secretion; Male; Pancreas; Prolactin; Somatostatin; Thyroxine; Triiodothyronine | 1998 |
Blockade of nitric oxide formation impairs adrenergic-induced ACTH and corticosterone secretion.
Topics: Adrenergic Agonists; Adrenocorticotropic Hormone; Animals; Clonidine; Corticosterone; Enzyme Inhibitors; Hypothalamo-Hypophyseal System; Isoproterenol; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Phenylephrine; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Adrenergic | 1999 |
Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters.
Topics: 1-Methyl-4-phenylpyridinium; Biological Transport; Caco-2 Cells; Carrier Proteins; Cations; Cell Line; Clonidine; Corticosterone; DNA, Recombinant; Dose-Response Relationship, Drug; Gene Expression; Histamine; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Intestines; Membrane Potentials; Membrane Proteins; Organic Cation Transport Proteins; Organic Cation Transporter 1; Plasmids; Quinolines; Quinolinium Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium; Tetraethylammonium; Time Factors; Transfection; Tritium | 2001 |
Involvement of constitutive (COX-1) and inducible cyclooxygenase (COX-2) in the adrenergic-induced ACTH and corticosterone secretion.
Topics: Adrenocorticotropic Hormone; Animals; Clenbuterol; Clonidine; Corticosterone; Corticotropin-Releasing Hormone; Cyclooxygenase 1; Cyclooxygenase 2; Hypothalamo-Hypophyseal System; Isoenzymes; Isoproterenol; Male; Membrane Proteins; Phenylephrine; Pituitary-Adrenal System; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Receptors, Adrenergic | 2001 |
Effect of social stress on COX-1 and COX-2-induced alterations in the adrenergic agonists-evoked hypothalamic-pituitary-adrenal responses.
Topics: Adrenocorticotropic Hormone; Animals; Clonidine; Corticosterone; Cyclooxygenase 1; Cyclooxygenase 2; Hypothalamo-Hypophyseal System; Isoenzymes; Isoproterenol; Male; Membrane Proteins; Nitric Oxide; Nitrobenzenes; Piroxicam; Pituitary-Adrenal System; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Wistar; Receptors, Adrenergic; Stress, Psychological; Sulfonamides | 2001 |
Effects of antisense oligodeoxynucleotide to the alpha2A-adrenoceptors on the plasma corticosterone level and on elevated plus-maze behavior in rats.
Topics: Adrenergic alpha-Agonists; Animals; Anxiety; Behavior, Animal; Cerebral Cortex; Clonidine; Corticosterone; Locus Coeruleus; Male; Microinjections; Oligonucleotides, Antisense; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
Gyrus cinguli transection abolishes delta-opioid receptor-induced gastroprotection and alters alpha 2 adrenoceptor activity in the lower brainstem in rats.
Topics: Adrenalectomy; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenocorticotropic Hormone; Animals; Arcuate Nucleus of Hypothalamus; beta-Endorphin; Brain Stem; Cisterna Magna; Clonidine; Corticosterone; Enkephalin, Leucine-2-Alanine; Ethanol; Gyrus Cinguli; Hypothalamo-Hypophyseal System; Limbic System; Male; Microinjections; Rats; Rats, Wistar; Receptors, Opioid, delta; Solvents; Stomach Ulcer | 2002 |
Evidence for alterations in alpha2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration.
Topics: Adrenergic alpha-Agonists; Animals; Brain; Clonidine; Cocaine; Cocaine-Related Disorders; Corticosterone; Depressive Disorder; Disease Models, Animal; Down-Regulation; Drug Administration Schedule; Growth Hormone; Male; Norepinephrine; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Substance Withdrawal Syndrome; Synaptic Transmission | 2004 |
Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver.
Topics: Animals; Axonal Transport; Bicuculline; Blood Glucose; Circadian Rhythm; Clonidine; Corticosterone; gamma-Aminobutyric Acid; Glucagon; Gluconeogenesis; Herpesvirus 1, Suid; Hyperglycemia; Hypothalamus; Insulin; Isoproterenol; Liver; Male; Microdialysis; Muscimol; N-Methylaspartate; Norepinephrine; Parasympathectomy; Parasympathetic Nervous System; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Suprachiasmatic Nucleus; Sympathectomy; Sympathetic Nervous System; Tetrodotoxin; Vasopressins | 2004 |
Systemic administration of leptin decreases plasma corticosterone levels: role of hypothalamic norepinephrine.
Topics: Adrenergic Agents; Animals; Clonidine; Corticosterone; Dose-Response Relationship, Drug; Hypothalamo-Hypophyseal System; Injections, Intravenous; Isoproterenol; Leptin; Male; Norepinephrine; Paraventricular Hypothalamic Nucleus; Phenylephrine; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha | 2008 |
Changes in HPA reactivity and noradrenergic functions regulate spatial memory impairments at delayed time intervals following cerebral ischemia.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Analysis of Variance; Animals; Brain; Brain Ischemia; Clonidine; Corticosterone; Hypothalamo-Hypophyseal System; Male; Maze Learning; Memory; Neurons; Norepinephrine; Pituitary-Adrenal System; Rats; Rats, Wistar; Time Factors; Yohimbine | 2011 |
The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Neurons; Adrenocorticotropic Hormone; alpha-Methyltyrosine; Analysis of Variance; Animals; Antihypertensive Agents; Clonidine; Corticosterone; Diazepam; Disease Models, Animal; Enzyme Inhibitors; Female; Hypnotics and Sedatives; Rats; Rats, Wistar; Reserpine; Yohimbine | 2012 |
Acute injections of corticosterone, norepinephrine and epinephrine retards food passage in the crop of chicks.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Animals, Newborn; Chickens; Clonidine; Corticosterone; Corticotropin-Releasing Hormone; Defecation; Epinephrine; Gastric Emptying; Isoproterenol; Male; Norepinephrine; Phenylephrine; Urocortins | 2016 |
Blood glucose regulation mechanism in depressive disorder animal model during hyperglycemic states.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Blood Glucose; Clonidine; Corticosterone; Depressive Disorder; Disease Models, Animal; Down-Regulation; Drug Administration Routes; Glucose; Glucose Tolerance Test; Hyperglycemia; Insulin; Male; Mice; Mice, Inbred ICR; Restraint, Physical; Time Factors; Up-Regulation | 2016 |
Effect of subchronic corticosterone administration on α
Topics: Animals; Anti-Inflammatory Agents; Clonidine; Corticosterone; Disease Models, Animal; Hypothalamo-Hypophyseal System; Locus Coeruleus; Male; Microdialysis; Norepinephrine; Pituitary-Adrenal System; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic | 2016 |
An exploration of the aversive properties of 2-deoxy-D-glucose in rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Analysis of Variance; Animals; Behavior, Animal; Blood Glucose; Bupropion; Clonidine; Corticosterone; Deoxyglucose; Disease Models, Animal; Dopamine Uptake Inhibitors; Hypoglycemia; Locomotion; Male; Norepinephrine; Rats; Rats, Sprague-Dawley | 2018 |
Leptin and HPA axis activity in diabetic rats: Effects of adrenergic agonists.
Topics: Adrenergic Agonists; Adrenergic alpha-Agonists; Animals; Clonidine; Corticosterone; Diabetes Mellitus, Experimental; Hypothalamo-Hypophyseal System; Isoproterenol; Leptin; Male; Norepinephrine; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley | 2019 |
Modulation of the HGF/c-Met Axis Impacts Prolonged Hematopoietic Progenitor Mobilization Following Trauma and Chronic Stress.
Topics: Animals; Clonidine; Corticosterone; Enzyme-Linked Immunosorbent Assay; Hematopoietic Stem Cells; Hepatocyte Growth Factor; Matrix Metalloproteinase 9; Propranolol; Proto-Oncogene Proteins c-met; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Shock, Hemorrhagic; Wounds and Injuries | 2020 |